Skip to content

Clinical trials

Completed Phase 3 Intestinal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intestinal Diseases Phase: Phase 3 Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20093
20111
20121
20131
20141
20151
20162
20171
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)3
Bausch Health Americas, Inc.2
Boehringer Ingelheim1
Furiex Pharmaceuticals, Inc1
Korea University Anam Hospital1
Medtronic - MITG1
Menarini Group1
Pharmbio Korea Co., Ltd.1
Seres Therapeutics, Inc.1
Shield Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intestinal Diseases16
Digestive System Diseases7
Gastrointestinal Diseases7
Colonic Diseases6
Rectal Diseases4
Constipation3
Inflammatory Bowel Diseases3
Pain3
Colitis2
Colitis, Ulcerative2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.